Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
about
Transmigration of neural stem cells across the blood brain barrier induced by glioma cellsEGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry.Metabotropic glutamate receptors as a new therapeutic target for malignant gliomasSalvage radiosurgery for selected patients with recurrent malignant gliomas.Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and sciencemTORC2 in the center of cancer metabolic reprogrammingmTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling.The ketogenic diet for the treatment of malignant glioma.The challenges and the promise of molecular targeted therapy in malignant gliomas.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.Extracellular RNAs: development as biomarkers of human disease.mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment.Emerging targets for glioblastoma stem cell therapyCorrelation of microRNA-372 upregulation with poor prognosis in human glioma.A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatmentsThe Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells In Vitro and In VivoAnti-cancer Therapies in High Grade Gliomas.Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.Molecular markers of glioma: an update on recent progress and perspectives.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Introduction, rationale, and methodology.Liquid biopsies in patients with diffuse glioma.Glioblastoma: pathology, molecular mechanisms and markers.Canine brain tumours: a model for the human disease?Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Serum microRNAs as potential noninvasive biomarkers for glioma.Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.ExRNA in Biofluids as Biomarkers for Brain Tumors.FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.Cytotoxic CD4+ T cells are correlated with better prognosis in Han Chinese grade II and grade III glioma subjects and are suppressed by PD-1 signaling.Association between RAD 51 rs1801320 and susceptibility to glioblastoma.Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.Rescuing defective tumor-infiltrating T-cell proliferation in glioblastoma patients.PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.Homozygous deletion of TNFRSF4, TP73, PPAP2B and DPYD at 1p and PDCD5 at 19q identified by multiplex ligation-dependent probe amplification (MLPA) analysis in pediatric anaplastic glioma with questionable oligodendroglial component.Targeted antiepidermal growth factor receptor (cetuximab) immunoliposomes enhance cellular uptake in vitro and exhibit increased accumulation in an intracranial model of glioblastoma multiforme.Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway.The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme.
P2860
Q27329613-F493A1AC-701F-4DB7-9F04-13669A9E23A0Q31110612-7298C315-A755-4B75-BC7C-B2E0104D99F6Q33591900-076A2804-79BC-44EE-8FAE-A2438B475EDBQ33661580-BD8756D3-EBB7-4C58-830C-C7DEB79EEF9DQ33746514-3E848CF2-F787-46FE-AF33-8803952B5377Q33831466-09E4F2E9-CA8A-44C5-AEE6-76D6F5B593ACQ33884658-192607BC-FC51-4D68-8831-4B38EAA176E2Q34757474-99FF438F-0EDD-4D1A-AF3F-947D9B2096D0Q35214534-148B8B7B-CC92-448F-868F-C0D692B31A75Q35794896-F0F9E1AF-65E4-4FC5-BE42-E685CD80B384Q35910243-4260179D-B62A-4AA1-8D31-087E8611FBE2Q35925760-CD8E48C3-423E-4405-BB18-05545A82DD68Q36006446-32304DB1-C759-41ED-A69C-67B9B95D4E7CQ36256815-4B43D690-4799-438D-B729-5C58802AB053Q36502009-B9ED93C1-1C31-4997-A76E-0F85549C47A7Q36552246-0EE1A020-64F2-4D76-9707-6EE1761CEFE1Q36740744-1BE940BF-D5A1-406B-8B4B-B228D8A7F9B7Q36832243-22198BCF-026E-4829-84C2-F64BC88114FAQ37290626-9AEE7D3E-786D-4BC4-B7C7-54AFE60A90A6Q38027227-92500434-0563-42A2-A2AD-99E66497934BQ38050966-4D0671E3-8B0F-473F-AB9D-CF07F54CB230Q38108186-06296903-5E10-4D01-9C5D-2ADAE6AA00A4Q38203242-21C67D0B-26E9-463E-8556-92571AC413FCQ38365590-1219C616-03A6-4A64-B6A7-A4E04FC296DBQ38460865-2EE187CA-83B3-43B2-BA29-9092E30D89C4Q38491009-3BFC54DD-4926-426D-BDAE-38A0A7CB1316Q38504172-71A32D69-5EF8-4D17-B2A9-CC44C79787FEQ38656215-B2C94262-4660-4071-A02C-357DA3466B68Q38706839-C45ED04D-E26B-482A-83C9-6ED65D6A7814Q38781031-5196DB65-EA2C-42DA-82BD-C4AB842FD842Q38999036-C0DD1293-3C0E-4473-9DB6-0337BB633249Q39775953-BC9915EE-79A8-41B1-8FA3-A6A4E716FDEBQ40382294-05065407-B3ED-4B0F-8E2C-3158BCF0F8DAQ40993120-1F9F95D3-A918-468B-ABE9-F6C7E2D19079Q41198335-A82754B5-B1D4-416C-8361-2AE171920DEEQ41818544-7841953A-AC1D-4D9A-BDF6-17565CB47A73Q41898533-079F9475-49D9-4760-B7DF-27DEA8688A7AQ42120982-C9E35539-3770-4785-8376-152190937484Q42578957-1073120B-0299-49A8-9A3B-6D131EC27982Q43819146-F6F67295-F699-4D6E-A96F-30DBDA8784CD
P2860
Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Review: molecular pathology in ...... iagnostics to target therapies
@ast
Review: molecular pathology in ...... iagnostics to target therapies
@en
type
label
Review: molecular pathology in ...... iagnostics to target therapies
@ast
Review: molecular pathology in ...... iagnostics to target therapies
@en
prefLabel
Review: molecular pathology in ...... iagnostics to target therapies
@ast
Review: molecular pathology in ...... iagnostics to target therapies
@en
P2093
P2860
P1476
Review: molecular pathology in ...... iagnostics to target therapies
@en
P2093
P S Mischel
T F Cloughesy
P2860
P304
P356
10.1111/J.1365-2990.2011.01238.X
P577
2012-06-01T00:00:00Z